Laboratory Equipment

London – October 07, 2026 -- The global cell culture monitoring biosensors market is set to more than double from USD 413.8 million in 2024 to USD 906.56 million by 2032, expanding at a 10.3% compound annual growth rate, according to a new report from Credence Research Inc. Demand is being driven by biologics manufacturers, cell therapy developers and high-throughput research labs shifting away from manual sampling toward continuous, non-invasive monitoring.

Optical biosensors dominate with 39% technology share in 2024

Optical platforms led the market on strength of real-time, label-free cell analysis capabilities. Electrochemical, mechanical and microfluidic biosensors are gaining ground as labs integrate sensing hardware with automated culture platforms to cut manual intervention and flag process deviations earlier.

Sheridan, Wyo. – October 05, 2026 -- The global in vitro diagnostics (IVD) quality control market is set to climb from $1.7 billion in 2026 to $2.2 billion by 2031, a 5.3% compound annual growth rate, according to a new study by Wissen Research.

Rising testing volumes and regulatory pressure push labs toward automated QC

Growth is driven by expanding testing complexity across clinical chemistry, immunoassay, hematology, and molecular diagnostics, combined with tightening regulatory requirements such as CLIA in the United States. Laboratories are increasingly adopting internal quality controls, third-party control materials, and external quality assessment programs as standard practice.

Delray Beach, Fla. – September 26, 2026 -- The global liquid handling system market will grow from $5.26 billion in 2026 to $7.79 billion by 2031, expanding at a compound annual growth rate of 8.2%, according to a new report from MarketsandMarkets.

Automated systems and pipettes lead segment growth

Automated systems held the largest share of the market in 2025 and are projected to post the highest CAGR of 9.0% through 2031, as pharmaceutical and biotechnology laboratories shift from manual liquid transfer to robotic platforms for pipetting, dispensing, dilution and microplate handling. Within product categories, pipettes accounted for the largest 2025 share and are forecast to grow fastest at 9.5% CAGR, driven by adoption of electronic and multi-channel pipetting systems that integrate with laboratory information management systems (LIMS) and support nanoliter-scale dispensing for genomics and cell and gene therapy workflows.

Delray Beach – September 20, 2026 -- The global Laboratory Information Management System (LIMS) market is projected to grow from USD 3.26 billion in 2026 to USD 5.84 billion by 2031, a compound annual growth rate of 12.4%, according to MarketsandMarkets.

Rising test volumes force labs to digitize workflows

The US Centers for Disease Control and Prevention estimates that healthcare professionals order more than 14 billion laboratory tests annually across over 266,000 CLIA-certified laboratories nationwide. In India, the RMLIMS platform recorded complete blood count testing rise from 236,289 to 331,541 procedures between 2023 and 2025, while molecular testing volumes climbed from 728 to 1,236 over the same period.

Richmond – September 19, 2026 -- Alps Dx has named 26-year diagnostics industry veteran Pam Lacock as vice president of sales and opened a new 2,030-square-foot headquarters and manufacturing hub in Richmond, Virginia, as the company shifts from product development toward broader commercialization of its oral fluid testing platform.

Washington – September 19, 2026 -- The Association for Diagnostics & Laboratory Medicine (ADLM) has formally recommended that artificial intelligence tools used in clinical laboratories remain subject to the same validation, quality-system, and monitoring requirements that govern traditional laboratory testing under the Clinical Laboratory Improvement Amendments (CLIA). The recommendation was submitted in a comment letter responding to a federal request for information on potential updates to CLIA, the regulatory framework that has governed U.S. clinical laboratory testing since 1992.

Delray Beach, Fla. – September 18, 2026 -- The global pipette calibration services market is projected to more than double to USD 834.8 million by 2031 from USD 383.2 million in 2026, a 16.9% compound annual growth rate, according to MarketsandMarkets.

North America controls half of global demand as regulatory pressure mounts

North America held a 50.6% share of the pipette calibration services market in 2025, underpinned by dense pharmaceutical and biotechnology infrastructure, federal biomedical research funding, and strict laboratory equipment qualification requirements. Thermo Fisher Scientific, Eppendorf, and Sartorius operate significant service footprints across the region, supporting clinical labs, academic institutions, and drug manufacturers requiring traceable measurement accuracy.

Melbourne – September 17, 2026 -- IonOpticks has released Aurora Series 5, a nano-LC column platform that sustained over 10,000 unique protein identifications across more than 1,000 injections in extended laboratory testing, without a rise in backpressure beyond 1,400 runs.

Extended testing confirms durability across 1,400-plus injections on an 8-minute, 120-samples-per-day method

Testing was conducted on a Thermo Scientific Vanquish Neo UHPLC coupled to an Orbitrap Astral Zoom mass spectrometer. IonOpticks says the results allow laboratories to run nanoflow-level depth and sensitivity as a routine, high-throughput workflow rather than reserving it for select experiments.

Delray Beach, Fla. – September 17, 2026 -- The global cryovials market is projected to grow from $0.24 billion in 2026 to $0.31 billion by 2031, expanding at a compound annual growth rate of 5.5%, according to MarketsandMarkets.

Cell and gene therapy demand drives fastest-growing application segment

The cell and gene therapy segment is set to register the highest CAGR among applications at 8.0%, fueled by expanding commercialization of CAR-T cell therapies, stem cell treatments, and gene-modified therapies. These advanced therapies require secure cryogenic storage across collection, processing, manufacturing, transportation, and administration to preserve cell viability. Manufacturers scaling from clinical to commercial production are prioritizing sterile, barcoded cryovials with secure closure systems compatible with automated storage.

Delray Beach, Fla. – September 16, 2026 -- The global biological safety cabinet market is projected to grow from USD 0.26 billion in 2026 to USD 0.36 billion by 2031, a 6.6% CAGR, according to MarketsandMarkets.

Pharma investment and biosafety upgrades drive containment equipment demand

Expansion of drug discovery, biologics, cell and gene therapy, and vaccine development is pushing laboratories to replace aging cabinets with certified, higher-performance containment systems. Rising biosafety requirements for handling infectious agents and hazardous materials are accelerating both new installations and equipment upgrades across clinical, academic, and pharmaceutical labs.